Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction

Calcineurin inhibitors (CNIs) are frequently given at a reduced dose in combination with mycophenolate mofetil (MMF) to avoid nephrotoxicity, but the optimal reduction in CNI dose has not been established. In this prospective, open-label, multicenter study, liver transplant recipients with chronic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pusen, Que, Weitao, Li, Hao, Yan, Lvnan, Fu, Zhiren, Ye, Qifa, Chen, Guihua, Dou, Kefeng, Lu, Shichun, Yang, Zhanyu, Zhu, Zhijun, Peng, Zhihai, Zhong, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593662/
https://www.ncbi.nlm.nih.gov/pubmed/28915690
http://dx.doi.org/10.18632/oncotarget.15490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593662/
https://www.ncbi.nlm.nih.gov/pubmed/28915690
http://dx.doi.org/10.18632/oncotarget.15490

Ejemplares similares